Biotech Strategic Finance & Growth: Complete Guide to IPO Preparation, Finance Courses, Investor Relations Training & M&A Strategies
For US biotech firms targeting 2024 growth, strategic finance mastery is urgent: 78% of biotech IPOs delay due to poor